Concepedia

Publication | Open Access

Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials

15

Citations

25

References

2018

Year

Abstract

Patients with T-cell ALL included in the HR-11 trial showed better OS than patients in the HR-03, mostly driven by a reduction of NRM.

References

YearCitations

Page 1